22:22 IST
NSE
Other Announcement
Medicamen Organics Other Announcement
Medicamen Organics Limited has re-appointed Ms. Divya Rani as the Secretarial Auditor of the company for a period of 12 months.
Medicamen Organics Ltd
- Share price
- ₹24.55
- Market cap
- ₹36.53 Cr
- Revenue (annual)
- ₹22.63 Cr
- Net profit (annual)
- ₹-4.02 Cr
- P/E (TTM)
- -9.1×Sector 47.4×
- Promoter holding
- 54.89%
- FII holding
- 0.05%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Other Announcement 6Management Change 5Annual General Meeting 5Fund Raise 4Financial Results 2Price Movement Clarification 1Debt & Borrowing 1Board Meeting Date 1
Time
6 announcements with these filters
17:08 IST
NSE
Other Announcement
Medicamen Organics Other Announcement
Medicamen Organics Limited informed shareholders about the web-link to access the Notice of the 31st AGM and Annual Report for FY 2025-26, as per regulatory compliance.
20:04 IST
NSE
Other Announcement
Medicamen Organics Other Announcement
Medicamen Organics Limited amended its Code of Practices for Fair Disclosure of Unpublished Price Sensitive Information. This update ensures compliance with current SEBI regulations.
13:48 IST
NSE
Other Announcement
Medicamen Organics Other Announcement
Medicamen Organics clarified potential re-computation of security prices for its ongoing preferential issue. Allotted securities will remain locked-in until any additional re-computed amounts are fully paid.
16:20 IST
NSE
Other Announcement
Medicamen Organics Other Announcement
Medicamen Organics Limited submitted its Structured Digital Database compliance certificate for the financial year ended March 31, 2026. Issued by M/s KNGC and Associate LLP, the certificate confirms the company maintained records for 19 required events as per SEBI PIT Regulations.
16:56 IST
NSE
Other Announcement
Medicamen Organics Other Announcement
Medicamen Organics Limited has updated its list of Key Managerial Personnel authorized to determine the materiality of events for disclosure under Regulation 30(5). The authorized personnel include Mr. Bal Kishan Gupta (MD), Mr. Lalit Gupta (CFO), and Ms. Divya Sharma (Company Secretary), following her appointment on April 17, 2026.